Mackaness James H's Form 4 filing
Soleno Therapeutics Inc (SLNO) · filed Aug 7, 2024
- Accession no.
- 0001415889-24-020945
- Filed
- Aug 7, 2024
- Trade date
- Aug 5-6, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $683.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mackaness James HCIK 0001422484 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2024 | Common Stock | SSaleDisposed | −3,858 | $45.48 | −$175,461.84 | 151,905 | Direct | |
| Aug 5, 2024 | Common Stock | SSaleDisposed | −2,991 | $46.14 | −$138,004.74 | 148,914 | Direct | |
| Aug 6, 2024 | Common Stock | SSaleDisposed | −799 | $43.64 | −$34,868.36 | 148,115 | Direct | |
| Aug 6, 2024 | Common Stock | SSaleDisposed | −2,699 | $45.25 | −$122,129.75 | 145,416 | Direct | |
| Aug 6, 2024 | Common Stock | SSaleDisposed | −4,636 | $45.89 | −$212,746.04 | 140,780 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.